Titre :
  • Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents: an expert agreement.
Auteur : Porta, C ; Tortora, Giampaolo ; Linassier, C ; Papazisis, K ; Awada, Ahmad ; Berthold, D ; Maroto, J P ; Powles, Trevor J ; De Santis, Maria
Informations sur la publication : Medical oncology, 29, 3, (page 1896-1907)
Statut de publication : Publié, 2012-09
Sujet CREF : Cancérologie
Mots-clés : Bevacizumab
Everolimus
Pazopanib
RCC
Renal cell carcinoma
Sequence
Sorafenib
Sunitinib
Temsirolimus
Tyrosine kinase inhibitor
Mots-clés MeSH : Antineoplastic Agents -- therapeutic use
Carcinoma, Renal Cell -- drug therapy
Clinical Trials as Topic
Drug Delivery Systems
Humans
Kidney Neoplasms -- drug therapy
Note : Journal Article
Research Support, Non-U.S. Gov't
Review
SCOPUS: re.j
Langue :
  • Anglais
Identificateurs : urn:issn:1357-0560 
info:doi/10.1007/s12032-011-0016-8
info:pmid/21735145